Episode breakdown:
00:00 – Tech Problems, AV Chaos, and Starting the Conversation
00:50 – Meet Adrian Mendes, CEO of Perimeter Medical
01:27 – How Perimeter Got on the Radar (and Chamath’s Backing)
02:17 – Chamath Explains the Breast Cancer Surgery Problem
04:47 – AI + Imaging to Eliminate Repeat Surgeries
06:34 – FDA Trials, Labeling, and the Road to Approval
07:23 – The Emotional and Clinical Impact of Re-Excisions
08:35 – How Surgeons Use Perimeter’s Current FDA-Cleared Device
09:52 – $700M Wasted Annually on Repeat Surgeries
10:59 – Cutting Re-Excisions to 5%: Hospital and Patient Benefits
12:07 – Why Medtech Needs Both Clinical and Economic Pathways
12:58 – Adrian’s AI Hardware Background and Move to Medtech
14:55 – How Optical Coherence Tomography (OCT) Works in the OR
16:27 – Imaging Comparison: OCT vs. Ultrasound vs. MRI vs. Pathology
17:59 – Building an AI + OCT Platform and Tissue Registry
19:22 – The Scale of the Market Opportunity Beyond Breast Cancer
20:55 – Why Breast Cancer Was the Beachhead Market
21:53 – Perimeter’s Business Model: Capital, Disposables, and AI Software
23:33 – Adoption, Workflow Integration, and Surgeon Response
25:49 – Confidence, Data, and Surgeon Feedback
27:02 – Demand Creation and Word-of-Mouth Growth
28:59 – Workflow Demo: How the Device Is Used in Surgery
30:49 – Patient Impact: Rural Access and Reduced Delays
32:31 – AI Levels the Playing Field for Community Hospitals
33:53 – PMA Submission and AI Clinical Trial Results (88.1% Accuracy)
35:57 – The Emotional Benefit of “First-Time-Right” Cancer Surgery
37:20 – Regulatory Progress and Commercial Updates
38:44 – Chamath’s Involvement and Why AI Differentiates Perimeter
40:05 – Quality Data vs. Big Data: Building a Proprietary Library
41:13 – Predictive Health, Earlier Detection, and Future Applications
42:24 – TechMed vs. Medtech: Why Perimeter Is a True Hybrid
43:07 – Looking Ahead: More Indications and Expanding Applications
43:53 – Closing Thoughts and Call to Action
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Subscribe to our LinkedIn Newsletter
https://www.stateofmedtechpodcast.com/
Follow The State of MedTech on
LinkedIn https://www.linkedin.com/company/thestateofmedtech
Instagram https://www.instagram.com/stateofmedtech/
TikTok https://www.tiktok.com/@stateofmedtech
X https://twitter.com/StateofMedTech
Facebook https://www.facebook.com/stateofmedtech/
Follow Omar M. Khateeb on
LinkedIn https://www.linkedin.com/in/okhateeb/
Instagram https://www.instagram.com/omar.m.khateeb/
TikTok https://www.tiktok.com/@omarkhateebofficial
X https://twitter.com/OmarMKhateeb
Facebook https://www.facebook.com/OmarMKhateeb/
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.
